Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,514.34
    +188.50 (+0.37%)
     
  • CMC Crypto 200

    1,367.36
    +54.74 (+4.17%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

New Strong Buy Stocks for May 5th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Corcept Therapeutics Incorporated (CORT): This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.

Corcept Therapeutics Incorporated Price and Consensus

 

Corcept Therapeutics Incorporated Price and Consensus
Corcept Therapeutics Incorporated Price and Consensus

Corcept Therapeutics Incorporated price-consensus-chart | Corcept Therapeutics Incorporated Quote

Iamgold Corporation (IAG): This gold mining company has seen the Zacks Consensus Estimate for its current year earnings increasing 21.1% over the last 60 days.

Iamgold Corporation Price and Consensus

 

Iamgold Corporation Price and Consensus
Iamgold Corporation Price and Consensus

Iamgold Corporation price-consensus-chart | Iamgold Corporation Quote

ADVERTISEMENT

Murphy USA Inc. (MUSA): This independent retailer of motor fuel and convenience merchandise has seen the Zacks Consensus Estimate for its current year earnings increasing 37.9% over the last 60 days.

Murphy USA Inc. Price and Consensus

 

Murphy USA Inc. Price and Consensus
Murphy USA Inc. Price and Consensus

Murphy USA Inc. price-consensus-chart | Murphy USA Inc. Quote

RELX PLC (RELX): This company that provides information solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 14.1% over the last 60 days.

RELX PLC Price and Consensus

 

RELX PLC Price and Consensus
RELX PLC Price and Consensus

RELX PLC price-consensus-chart | RELX PLC Quote

Cogent Communications Holdings, Inc. (CCOI): This Tier 1 Internet Service Provider (ISP) has seen the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.

Cogent Communications Holdings, Inc. Price and Consensus

 

Cogent Communications Holdings, Inc. Price and Consensus
Cogent Communications Holdings, Inc. Price and Consensus

Cogent Communications Holdings, Inc. price-consensus-chart | Cogent Communications Holdings, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
RELX PLC (RELX) : Free Stock Analysis Report
 
Murphy USA Inc. (MUSA) : Free Stock Analysis Report
 
Iamgold Corporation (IAG) : Free Stock Analysis Report
 
Corcept Therapeutics Incorporated (CORT) : Free Stock Analysis Report
 
Cogent Communications Holdings, Inc. (CCOI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research